Company Information for SENTINEL ONCOLOGY LIMITED
181 SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CAMBRIDGESHIRE, CB4 0GJ,
|
Company Registration Number
05336536
Private Limited Company
Active |
Company Name | |
---|---|
SENTINEL ONCOLOGY LIMITED | |
Legal Registered Office | |
181 SCIENCE PARK MILTON ROAD CAMBRIDGE CAMBRIDGESHIRE CB4 0GJ Other companies in CB4 | |
Company Number | 05336536 | |
---|---|---|
Company ID Number | 05336536 | |
Date formed | 2005-01-19 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/03/2023 | |
Account next due | 31/12/2024 | |
Latest return | 19/01/2016 | |
Return next due | 16/02/2017 | |
Type of accounts | TOTAL EXEMPTION FULL | |
VAT Number /Sales tax ID | GB857141715 |
Last Datalog update: | 2024-02-05 10:35:19 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
STUART TRAVERS |
||
ROBERT GEORGE BOYLE |
||
DANIEL COWELL |
||
JOHN DIXON |
||
GAVIN ALEXANDER SIMPSON |
||
STUART TRAVERS |
||
ASHOK VENKITARAMAN |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
GERALDINE ANNE RODGERS |
Director | ||
ALAN PAUL CHORLTON |
Director | ||
DAVID JOSZEF TAPOLCZAY |
Director | ||
JOHN TAYLOR STEWART |
Company Secretary | ||
ABERGAN REED NOMINEES LIMITED |
Nominated Secretary | ||
ABERGAN REED LIMITED |
Nominated Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
NEOPHORE LIMITED | Director | 2017-11-08 | CURRENT | 2017-05-09 | Active | |
MEDEOR OLD LIMITED | Director | 2009-03-20 | CURRENT | 2006-09-18 | Active | |
XENOGESIS LIMITED | Director | 2011-12-09 | CURRENT | 2011-02-24 | Active | |
NEW MEDICINES DISCOVERY LIMITED | Director | 2009-09-04 | CURRENT | 2009-09-04 | Dissolved 2015-06-16 | |
J D INTERNATIONAL CONSULTING LIMITED | Director | 2008-07-25 | CURRENT | 2008-07-25 | Active | |
PHOREMOST LIMITED | Director | 2014-04-01 | CURRENT | 2014-04-01 | Active | |
PHENOMICA LIMITED | Director | 2011-07-18 | CURRENT | 2011-07-14 | Dissolved 2016-05-24 |
Date | Document Type | Document Description |
---|---|---|
CONFIRMATION STATEMENT MADE ON 19/01/24, WITH UPDATES | ||
Amended account full exemption | ||
CONFIRMATION STATEMENT MADE ON 19/01/23, WITH NO UPDATES | ||
31/03/22 ACCOUNTS TOTAL EXEMPTION FULL | ||
AA | 31/03/22 ACCOUNTS TOTAL EXEMPTION FULL | |
CONFIRMATION STATEMENT MADE ON 19/01/22, WITH UPDATES | ||
CS01 | CONFIRMATION STATEMENT MADE ON 19/01/22, WITH UPDATES | |
AA | 31/03/21 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 19/01/21, WITH NO UPDATES | |
AD01 | REGISTERED OFFICE CHANGED ON 29/06/20 FROM 20 Station Road Cambridge Cambridgeshire CB1 2JD United Kingdom | |
AA | 31/03/20 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 19/01/20, WITH NO UPDATES | |
AA | 31/03/19 ACCOUNTS TOTAL EXEMPTION FULL | |
AD01 | REGISTERED OFFICE CHANGED ON 19/03/19 FROM Suite 52 23 Science Park Milton Road Cambridge Cambridgeshire CB4 0EY | |
CS01 | CONFIRMATION STATEMENT MADE ON 19/01/19, WITH NO UPDATES | |
AA | 31/03/18 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 19/01/18, WITH NO UPDATES | |
AA | 31/03/17 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 19/01/17, WITH UPDATES | |
LATEST SOC | 09/01/17 STATEMENT OF CAPITAL;GBP 7.858514 | |
SH01 | 05/12/16 STATEMENT OF CAPITAL GBP 7.858514 | |
RES13 | Resolutions passed:The directors of the company be authories to allot 335,514 ordinary shares of £0.000001 each in the capital of the company up to an aggregate nominal amount ofn£0.335514 In the respective proportions to such individuals. In accorda... | |
AA | 31/03/16 ACCOUNTS TOTAL EXEMPTION SMALL | |
RES01 | ADOPT ARTICLES 05/09/16 | |
LATEST SOC | 27/01/16 STATEMENT OF CAPITAL;GBP 7.523 | |
AR01 | 19/01/16 ANNUAL RETURN FULL LIST | |
AA | 31/03/15 ACCOUNTS TOTAL EXEMPTION SMALL | |
RES01 | ADOPT ARTICLES 26/02/15 | |
LATEST SOC | 19/01/15 STATEMENT OF CAPITAL;GBP 7.523 | |
AR01 | 19/01/15 ANNUAL RETURN FULL LIST | |
AA | 31/03/14 ACCOUNTS TOTAL EXEMPTION SMALL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR GERALDINE RODGERS | |
LATEST SOC | 23/01/14 STATEMENT OF CAPITAL;GBP 7.523 | |
AR01 | 19/01/14 ANNUAL RETURN FULL LIST | |
AA | 31/03/13 ACCOUNTS TOTAL EXEMPTION SMALL | |
AR01 | 19/01/13 ANNUAL RETURN FULL LIST | |
SH02 | Sub-division of shares on 2012-12-11 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / PROFESSOR ASHOK VENKITARAMAN / 26/11/2012 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR GERALDINE ANNE RODGERS / 26/11/2012 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / STUART TRAVERS / 26/11/2012 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / ROBERT GEORGE BOYLE / 26/11/2012 | |
CH03 | SECRETARY'S DETAILS CHNAGED FOR STUART TRAVERS on 2012-11-26 | |
SH01 | 11/09/12 STATEMENT OF CAPITAL GBP 7.523 | |
AA | 31/03/12 TOTAL EXEMPTION SMALL | |
SH01 | 19/03/12 STATEMENT OF CAPITAL GBP 6.106 | |
AR01 | 19/01/12 FULL LIST | |
AA | 31/03/11 TOTAL EXEMPTION SMALL | |
AP01 | DIRECTOR APPOINTED MR DANIEL ROWLAND COWELL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ALAN CHORLTON | |
AR01 | 19/01/11 FULL LIST | |
AD01 | REGISTERED OFFICE CHANGED ON 25/01/2011 FROM 23 CAMBRIDGE SCIENCE PARK SUITE 51 MILTON ROAD CAMBRIDGE CB4 0EY | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
RES01 | ALTER ARTICLES 28/05/2010 | |
AA | 31/03/10 TOTAL EXEMPTION SMALL | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
SH08 | NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES | |
AP01 | DIRECTOR APPOINTED DR ALAN CHORLTON | |
AP01 | DIRECTOR APPOINTED DR JOHN DIXON | |
AR01 | 19/01/10 FULL LIST | |
AD02 | SAIL ADDRESS CREATED | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / PROFESSOR ASHOK VENKITARAMAN / 21/01/2010 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / STUART TRAVERS / 21/01/2010 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / GAVIN ALEXANDER SIMPSON / 25/01/2010 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR GERALDINE ANNE RODGERS / 21/01/2010 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / ROBERT GEORGE BOYLE / 21/01/2010 | |
AA | 31/03/09 TOTAL EXEMPTION SMALL | |
AAMD | AMENDED EXEMPTION SMALL ACCOUNTS MADE UP TO 31/03/08 | |
363a | RETURN MADE UP TO 19/01/09; FULL LIST OF MEMBERS | |
288b | APPOINTMENT TERMINATED DIRECTOR DAVID TAPOLCZAY | |
AA | 31/03/08 TOTAL EXEMPTION SMALL | |
363a | RETURN MADE UP TO 19/01/08; FULL LIST OF MEMBERS | |
AA | TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 31/03/07 | |
190 | LOCATION OF DEBENTURE REGISTER | |
353 | LOCATION OF REGISTER OF MEMBERS | |
287 | REGISTERED OFFICE CHANGED ON 12/02/07 FROM: 106 HIGH STREET MEPPERSHALL SHEFFORD BEDFORDSHIRE SG17 5LZ | |
363a | RETURN MADE UP TO 19/01/07; FULL LIST OF MEMBERS | |
288a | NEW DIRECTOR APPOINTED | |
RES13 | SHARES DESIGNATED 19/01/07 | |
RES01 | ALTERATION TO MEMORANDUM AND ARTICLES | |
88(2)R | AD 19/01/07--------- £ SI 754@.001 £ IC 1/1 | |
AA | TOTAL EXEMPTION SMALL ACCOUNTS MADE UP TO 31/03/06 | |
288a | NEW SECRETARY APPOINTED | |
288b | SECRETARY RESIGNED | |
225 | ACC. REF. DATE EXTENDED FROM 31/01/06 TO 31/03/06 | |
288a | NEW DIRECTOR APPOINTED | |
288a | NEW DIRECTOR APPOINTED | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ALTERATION TO MEMORANDUM AND ARTICLES | |
88(2)R | AD 27/03/06--------- £ SI 371@.001 £ IC 1/1 | |
363s | RETURN MADE UP TO 19/01/06; FULL LIST OF MEMBERS | |
RES04 | £ NC 100/1000000 30/1 | |
122 | S-DIV 30/11/05 | |
123 | NC INC ALREADY ADJUSTED 30/11/05 | |
RES13 | SUBDIVISON OF SHARES 30/11/05 | |
288a | NEW DIRECTOR APPOINTED | |
288a | NEW DIRECTOR APPOINTED | |
288a | NEW SECRETARY APPOINTED | |
288a | NEW DIRECTOR APPOINTED |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max | |
MortgagesNumMortCharges | 0.33 | 8 |
MortgagesNumMortOutstanding | 0.17 | 8 |
MortgagesNumMortPartSatisfied | 0.00 | 1 |
MortgagesNumMortSatisfied | 0.16 | 8 |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
Creditors Due Within One Year | 2012-04-01 | £ 249,760 |
---|
Creditors and other liabilities
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on SENTINEL ONCOLOGY LIMITED
Called Up Share Capital | 2012-04-01 | £ 7 |
---|---|---|
Cash Bank In Hand | 2012-04-01 | £ 54,237 |
Current Assets | 2012-04-01 | £ 247,596 |
Debtors | 2012-04-01 | £ 116,513 |
Fixed Assets | 2012-04-01 | £ 66,860 |
Shareholder Funds | 2012-04-01 | £ 64,696 |
Stocks Inventory | 2012-04-01 | £ 76,846 |
Tangible Fixed Assets | 2012-04-01 | £ 2,303 |
Debtors and other cash assets
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as SENTINEL ONCOLOGY LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
29420000 | Separate chemically defined organic compounds, n.e.s. |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Category | Award/Grant | |
---|---|---|
Development of an Investigational New Drug for the treatment of pancreatic cancer : Feasibility Study | 2013-02-01 | £ 1,786,182 |
Novel first in class p70S6 kinase inhibitors: Definition of clinical development path : Feasibility Study | 2012-10-01 | £ 149,508 |
Sentinel Oncology – Optimisation of Chk1 inhibitors for treatment of Glioblastoma : Smart - Proof of Concept | 2012-01-01 | £ 100,000 |
SOLBIO : European | 2011-03-01 | £ 256,410 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |